Logo Sarepta Therapeutics

Sarepta Therapeutics (SRPT) stock: analyst price target and their real reliability

Live quote · data updated Aug 28, 2026
Sarepta Therapeutics · Health Care · ref. ETF XLV · 204 calls · price $21.59
🏆JPI 2026 portfoliosSee tracking →
What the company does: Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, siRNA platform, gene therapy, and other genetic therapeutic modalities for the treatment of rare diseases.

📈 Sarepta Therapeutics (SRPT) stock price

$21.59+17.7% over range
Aug 28, 25low $14.86 · high $24.45Aug 27, 26
📏 Click 2 points (left → right) to measure the change · click again to clear.
SellBuy
Hold
43% recommend buying · 7 analysts
📊 JPI status : Sarepta Therapeutics has never appeared in a JPI ranking (Fair or Risk +) — our methods haven't picked it to date. See the selected stocks →

🎯 SRPT price target & analyst consensusprice $21.59

The price target · all analysts combined (7 targets)
Highest target · 1 firm of 7$37+71.4%
Median target · of 7 targets$27+25.1%
Lowest target · 1 firm of 7$13-39.8%
Current price$21.59
Where these 7 targets sit · versus the current price · 1 target per firm, last 6 months
Above the price 457% $27 ↔ $38
Below 343% $5 ↔ $20
⭐ What the most reliable analysts say

No reliable analyst is bullish on this stock right now. A “reliable” analyst is a firm that, on this sector, hits more than 55% of its targets and beats its sector. None of them sees upside here — which is exactly why this stock is in no JPI selection.

The consensus · 7 ratings (last 6 months)
Strong Buy00%
Buy343%
Hold114%
Sell343%
Strong Sell00%
Go deeper on the analysts
All analysts (the consensus)  ·  vs  ·  the best (those who've been right)
💬 A question about Sarepta Therapeutics? The JPI assistant answers using our backtest data.

🔎 Detailed analyses

🏛️ Which US Congress members hold Sarepta Therapeutics (SRPT)?

3 Congress members have disclosed SRPT buys. Click a highlighted name to see their track record (do they beat the S&P 500?).
Gilbert Cisneros · 48%Josh Gottheimer · 56%Daniel Goldman · 25%
→ Full members ranking (who beats the market)

✅ Historical analyst reliability on SRPT

Hit rate measured on targets already matured (12 months), replayed against real prices. Click a header to sort.

Firm % right i Gain vs sector i Calls i
Credit Suisse 90% +50.4% 10
Wedbush  82% +60.1% 11
HC Wainwright & Co.  80% +55.1% 15
Janney Montgomery Scott 60% +27.9% 5
JP Morgan  60% +15.6% 15
Morgan Stanley  58% +12.7% 19
Citigroup  50% +9.6% 12
BTIG  50% -2.2% 4
Guggenheim  50% -11.1% 4
WBB Securities 50% -55.7% 2
See the other 25 firms
BMO Capital  0% -64.5% 4
JMP Securities 0% -63.7% 2
Canaccord Genuity  0% -44.5% 3
William Blair  0% -32.0% 3
Evercore ISI Group  0% -30.4% 7
UBS  0% -25.3% 4
Roth Capital 0% -22.0% 2
Cowen & Co. 0% -13.8% 2
Piper Sandler  18% -20.0% 17
SVB Leerink 20% -10.1% 5
Mizuho  22% -19.7% 9
Jefferies  25% -57.1% 4
Baird  27% -20.6% 11
SunTrust Robinson Humphrey 33% -33.3% 3
Needham  33% -21.6% 42
Barclays  33% -18.8% 9
Wells Fargo  33% -12.1% 6
Deutsche Bank  33% -7.2% 6
Nomura 33% +24.8% 3
Cantor Fitzgerald  36% -22.6% 11
Oppenheimer  36% +1.6% 11
Goldman Sachs  40% +11.8% 5
Leerink Swann 40% +13.1% 5
RBC Capital  41% -15.7% 29
B of A Securities  44% -0.2% 27

📊 What $1,000 invested in Sarepta Therapeutics would be worth › open the full page

In short — $1,000 invested in Sarepta Therapeutics 10 years ago would be worth $466 today, i.e. -7%/yr on average. Best year: 2017 (+103%), worst: 2025 (-82%). Price performance, excluding dividends.

If I'd invested $1,000 in Sarepta Therapeutics

InvestmentWorth todayGain
1 years ago$148-85%
3 years ago$139-86%
5 years ago$105-89%
→ See Sarepta Therapeutics's full return history + gain calculator

Return by year (Sarepta Therapeutics)

YearReturn$1,000 invested at year start
2026 (YTD)-17%$835 (-17%)
2025-82%$148 (-85%)
2024+26%$186 (-81%)
→ See Sarepta Therapeutics's full return history + gain calculator
⚠️ Past performance, not predictive nor advice. Prices in $, excluding dividends. Yahoo Finance data.

📰 Recent news on Sarepta Therapeutics

Loading news…

📋 All analyst calls on SRPT

Piper Sandler 
Jul 9, 26
■ Neutral neutral · not a buy · 🎯$20
Price at call : $18.95 — gap to target +6%
Today : $21.59 — gap to target -7%
🎯 on SRPT : 8% (12 calls matureds) · 📊 on Health : 45.8% · +6.9% (249 calls)
in progress (365j)
matures : Jul 9, 27
▲ Outperform · 🎯$27
Price at call : $20.52 — upside +32%
Today : $21.59 — upside +25%
🎯 on SRPT : no call matured yet · 📊 overall : 35.2% · -2.7% (105 calls)
in progress (365j)
matures : Jul 9, 27
▼ Sell · 🎯$5
Price at call : $21.55 — upside -77%
Today : $21.59 — upside -77%
🎯 on SRPT : 83% (12 calls matureds) · 📊 on Health : 57.9% · +25.9% (321 calls)
in progress (365j)
matures : Apr 16, 27
Citigroup 
Mar 26, 26
▼ Sell · 🎯$13
Price at call : $19.97 — upside -35%
Today : $21.59 — upside -40%
🎯 on SRPT : 50% (12 calls matureds) · 📊 on Health : 43.8% · -5.4% (105 calls)
in progress (365j)
matures : Mar 26, 27
Needham 
Mar 26, 26
▼ Underperform
🎯 on SRPT : 8% (12 calls matureds) · 📊 on Health : 39% · -2.9% (397 calls)
in progress (365j)
matures : Mar 26, 27
Oppenheimer 
Mar 19, 26
▲ Outperform · 🎯$37
Price at call : $16.69 — upside +122%
Today : $21.59 — upside +71%
🎯 on SRPT : 36% (11 calls matureds) · 📊 on Health : 47.3% · +6.3% (93 calls)
in progress (365j)
matures : Mar 19, 27
Mizuho 
Mar 13, 26
▲ Outperform · 🎯$31
Price at call : $16.66 — upside +86%
Today : $21.59 — upside +44%
🎯 on SRPT : 22% (9 calls matureds) · 📊 on Health : 26.4% · -9.4% (87 calls)
in progress (365j)
matures : Mar 13, 27
Citigroup 
Mar 10, 26
▼ Sell · 🎯$9
Price at call : $17.58 — upside -49%
Today : $21.59 — upside -58%
🎯 on SRPT : 50% (12 calls matureds) · 📊 on Health : 43.8% · -5.4% (105 calls)
in progress (365j)
matures : Mar 10, 27
See the other 196 calls, newest to oldest
▼ Sell · 🎯$5
Price at call : $16.32 — upside -69%
Today : $21.59 — upside -77%
🎯 on SRPT : 83% (12 calls matureds) · 📊 on Health : 57.9% · +25.9% (321 calls)
in progress (365j)
matures : Mar 2, 27
Wells Fargo 
Feb 27, 26
▲ Overweight · 🎯$38
Price at call : $16.32 — upside +133%
Today : $21.59 — upside +76%
🎯 on SRPT : 50% (2 calls matureds) · 📊 on Health : 37.5% · +1.0% (104 calls)
in progress (365j)
matures : Feb 27, 27
▼ Sell · 🎯$5
Price at call : $22.17 — upside -77%
Today : $21.59 — upside -77%
🎯 on SRPT : 83% (12 calls matureds) · 📊 on Health : 57.9% · +25.9% (321 calls)
in progress (365j)
matures : Jan 27, 27
Wedbush 
Jan 23, 26
▲ Outperform · 🎯$34
Price at call : $21.13 — upside +61%
Today : $21.59 — upside +57%
🎯 on SRPT : 82% (11 calls matureds) · 📊 on Health : 35.8% · +3.2% (53 calls)
in progress (365j)
matures : Jan 23, 27
▼ Sell · 🎯$5
Price at call : $22.8 — upside -78%
Today : $21.59 — upside -77%
🎯 on SRPT : 83% (12 calls matureds) · 📊 on Health : 57.9% · +25.9% (321 calls)
in progress (365j)
matures : Jan 14, 27
Wedbush 
Dec 9, 25
▲ Outperform · 🎯$32
Price at call : $22.17 — upside +44%
Today : $21.59 — upside +48%
🎯 on SRPT : 82% (11 calls matureds) · 📊 on Health : 35.8% · +3.2% (53 calls)
in progress (365j)
matures : Dec 9, 26
Barclays 
Nov 5, 25
■ Equal-Weight neutral · not a buy · 🎯$20
Price at call : $17.64 — gap to target +13%
Today : $21.59 — gap to target -7%
🎯 on SRPT : 0% (1 call matured) · 📊 on Health : 37.3% · -8.4% (150 calls)
in progress (365j)
matures : Nov 5, 26
Wells Fargo 
Nov 5, 25
▲ Overweight · 🎯$45
Price at call : $17.64 — upside +155%
Today : $21.59 — upside +108%
🎯 on SRPT : 50% (2 calls matureds) · 📊 on Health : 37.5% · +1.0% (104 calls)
in progress (365j)
matures : Nov 5, 26
Guggenheim 
Nov 5, 25
▲ Buy · 🎯$19
Price at call : $17.64 — upside +8%
Today : $21.59 — upside -12%
🎯 on SRPT : no call matured yet · 📊 on Health : 67.3% · +19.3% (49 calls)
in progress (365j)
matures : Nov 5, 26
Mizuho 
Nov 5, 25
▲ Outperform · 🎯$26
Price at call : $18.67 — upside +39%
Today : $21.59 — upside +20%
🎯 on SRPT : 22% (9 calls matureds) · 📊 on Health : 26.4% · -9.4% (87 calls)
in progress (365j)
matures : Nov 5, 26
Baird 
Nov 4, 25
■ Neutral neutral · not a buy · 🎯$15
Price at call : $18.67 — gap to target -20%
Today : $21.59 — gap to target -31%
🎯 on SRPT : 27% (11 calls matureds) · 📊 on Health : 37.8% · -2.8% (82 calls)
in progress (365j)
matures : Nov 4, 26
Piper Sandler 
Oct 30, 25
■ Neutral neutral · not a buy · 🎯$16
Price at call : $24.01 — gap to target -33%
Today : $21.59 — gap to target -26%
🎯 on SRPT : 8% (12 calls matureds) · 📊 on Health : 45.8% · +6.9% (249 calls)
in progress (365j)
matures : Oct 30, 26
BMO Capital 
Sep 22, 25
▲ Outperform · 🎯$50
Price at call : $18.65 — upside +168%
Today : $21.59 — upside +132%
🎯 on SRPT : no call matured yet · 📊 on Health : 43.9% · -2.1% (66 calls)
in progress (365j)
matures : Sep 22, 26
Guggenheim 
Sep 15, 25
▲ Buy · 🎯$22
Price at call : $17.47 — upside +26%
Today : $21.59 — upside +2%
🎯 on SRPT : no call matured yet · 📊 on Health : 67.3% · +19.3% (49 calls)
in progress (365j)
matures : Sep 15, 26
■ Market Perform neutral · not a buy · 🎯$15
Price at call : $17.22 — gap to target -13%
Today : $21.59 — gap to target -31%
🎯 on SRPT : 0% (1 call matured) · 📊 on Health : 50% · -5.3% (10 calls)
in progress (365j)
matures : Sep 9, 26
▼ Sell · 🎯$5
Price at call : $18.06 — upside -72%
Today : $21.59 — upside -77%
Expected -72% · Actual +5% · Reason (≤ −15%) : ✗ No
🎯 on SRPT : 83% (12 calls matureds) · 📊 on Health : 57.9% · +25.9% (321 calls)
-4.8%
stock +5% · XLV +29%
matured Aug 25, 26
▼ Underperform · 🎯$16
Price at call : $20.22 — upside -21%
Today : $21.59 — upside -26%
Expected -21% · Actual -10% · Reason (≤ −15%) : ✗ No
🎯 on SRPT : 42% (12 calls matureds) · 📊 on Health : 51.3% · +3.0% (152 calls)
+10.3%
stock -10% · XLV +26%
matured Aug 21, 26
▼ Underperform · 🎯$17
Price at call : $20.58 — upside -17%
Today : $21.59 — upside -21%
Expected -17% · Actual -7% · Reason (≤ −15%) : ✗ No
🎯 on SRPT : 42% (12 calls matureds) · 📊 on Health : 51.3% · +3.0% (152 calls)
+6.6%
stock -7% · XLV +25%
matured Aug 20, 26
Deutsche Bank 
Aug 15, 25
▼ Sell · 🎯$12
Price at call : $20.99 — upside -43%
Today : $21.59 — upside -44%
Expected -43% · Actual -13% · Reason (≤ −15%) : ✗ No
🎯 on SRPT : 50% (2 calls matureds) · 📊 on Health : 32.7% · -7.6% (55 calls)
+13.4%
stock -13% · XLV +23%
matured Aug 15, 26
Goldman Sachs 
Aug 7, 25
■ Neutral neutral · not a buy · 🎯$19
Price at call : $18.23 — gap to target +4%
Today : $21.59 — gap to target -12%
🎯 on SRPT : no call matured yet · 📊 on Health : 51% · +5.1% (102 calls)
in progress (365j)
matures : Aug 7, 26
Wells Fargo 
Aug 7, 25
▲ Overweight · 🎯$50
Price at call : $18.23 — upside +174%
Today : $21.59 — upside +132%
Expected +174% · Actual -6% · Reason (≥ +15%) : ✗ No
🎯 on SRPT : 50% (2 calls matureds) · 📊 on Health : 37.5% · +1.0% (104 calls)
-5.8%
stock -6% · XLV +29%
matured Aug 7, 26
Barclays 
Jul 30, 25
■ Equal-Weight neutral · not a buy · 🎯$22
Price at call : $16.75 — gap to target +31%
Today : $21.59 — gap to target +2%
🎯 on SRPT : 0% (1 call matured) · 📊 on Health : 37.3% · -8.4% (150 calls)
in progress (365j)
matures : Jul 30, 26
Barclays 
Jul 29, 25
■ Equal-Weight neutral · not a buy · 🎯$22
Price at call : $16.75 — gap to target +31%
Today : $21.59 — gap to target +2%
🎯 on SRPT : 0% (1 call matured) · 📊 on Health : 37.3% · -8.4% (150 calls)
in progress (365j)
matures : Jul 29, 26
Bernstein 
Jul 29, 25
■ Market Perform neutral · not a buy · 🎯$13
Price at call : $16.75 — gap to target -22%
Today : $21.59 — gap to target -40%
🎯 on SRPT : no call matured yet · 📊 on Health : 25% · -33.8% (4 calls)
in progress (365j)
matures : Jul 29, 26
BMO Capital 
Jul 29, 25
■ Market Perform neutral · not a buy · 🎯$50
Price at call : $16.75 — gap to target +199%
Today : $21.59 — gap to target +132%
🎯 on SRPT : no call matured yet · 📊 on Health : 43.9% · -2.1% (66 calls)
in progress (365j)
matures : Jul 29, 26
Piper Sandler 
Jul 29, 25
■ Neutral neutral · not a buy · 🎯$15
Price at call : $15.83 — gap to target -5%
Today : $21.59 — gap to target -31%
🎯 on SRPT : 8% (12 calls matureds) · 📊 on Health : 45.8% · +6.9% (249 calls)
in progress (365j)
matures : Jul 29, 26
Morgan Stanley 
Jul 29, 25
■ Equal-Weight neutral · not a buy · 🎯$20
Price at call : $15.83 — gap to target +26%
Today : $21.59 — gap to target -7%
🎯 on SRPT : 42% (12 calls matureds) · 📊 on Health : 55.5% · +4.6% (182 calls)
in progress (365j)
matures : Jul 29, 26
Oppenheimer 
Jul 29, 25
▲ Outperform · 🎯$37
Price at call : $15.83 — upside +134%
Today : $21.59 — upside +71%
Expected +134% · Actual -2% · Reason (≥ +15%) : ✗ No
🎯 on SRPT : 36% (11 calls matureds) · 📊 on Health : 47.3% · +6.3% (93 calls)
-1.8%
stock -2% · XLV +24%
matured Jul 29, 26
JP Morgan 
Jul 29, 25
■ Neutral neutral · not a buy · 🎯$24
Price at call : $15.83 — gap to target +52%
Today : $21.59 — gap to target +11%
🎯 on SRPT : 50% (12 calls matureds) · 📊 on Health : 49.3% · +6.9% (146 calls)
in progress (365j)
matures : Jul 29, 26
Needham 
Jul 29, 25
▼ Underperform
Actual -2% · Reason (≤ −15%) : ✗ No
🎯 on SRPT : 8% (12 calls matureds) · 📊 on Health : 39% · -2.9% (397 calls)
+1.8%
stock -2% · XLV +24%
matured Jul 29, 26
Needham 
Jul 28, 25
▼ Underperform
Actual +11% · Reason (≤ −15%) : ✗ No
🎯 on SRPT : 8% (12 calls matureds) · 📊 on Health : 39% · -2.9% (397 calls)
-11.3%
stock +11% · XLV +24%
matured Jul 28, 26
Barclays 
Jul 27, 25
▼ Underweight · 🎯$10
Price at call : $13.86 — upside -28%
Today : $21.59 — upside -54%
Expected -28% · Actual +11% · Reason (≤ −15%) : ✗ No
🎯 on SRPT : 0% (1 call matured) · 📊 on Health : 37.3% · -8.4% (150 calls)
-11.3%
stock +11% · XLV +24%
matured Jul 27, 26
Deutsche Bank 
Jul 25, 25
▼ Sell · 🎯$6
Price at call : $13.86 — upside -57%
Today : $21.59 — upside -72%
Expected -57% · Actual +15% · Reason (≤ −15%) : ✗ No
🎯 on SRPT : 50% (2 calls matureds) · 📊 on Health : 32.7% · -7.6% (55 calls)
-14.6%
stock +15% · XLV +21%
matured Jul 25, 26
JP Morgan 
Jul 25, 25
▼ Underweight
Actual +33% · Reason (≤ −15%) : ✗ No
🎯 on SRPT : 50% (12 calls matureds) · 📊 on Health : 49.3% · +6.9% (146 calls)
-33.2%
stock +33% · XLV +20%
matured Jul 25, 26
Jefferies 
Jul 24, 25
▲ Buy · 🎯$35
Price at call : $11.93 — upside +193%
Today : $21.59 — upside +62%
Expected +193% · Actual +33% · Reason (≥ +15%) : ✓ Yes
🎯 on SRPT : 100% (1 call matured) · 📊 on Health : 50% · +9.9% (136 calls)
+33.2%
stock +33% · XLV +20%
matured Jul 24, 26
Wells Fargo 
Jul 24, 25
▲ Overweight · 🎯$48
Price at call : $11.93 — upside +302%
Today : $21.59 — upside +122%
Expected +302% · Actual +33% · Reason (≥ +15%) : ✓ Yes
🎯 on SRPT : 50% (2 calls matureds) · 📊 on Health : 37.5% · +1.0% (104 calls)
+33.2%
stock +33% · XLV +20%
matured Jul 24, 26
Citigroup 
Jul 24, 25
▼ Sell · 🎯$7
Price at call : $12.88 — upside -46%
Today : $21.59 — upside -68%
Expected -46% · Actual +22% · Reason (≤ −15%) : ✗ No
🎯 on SRPT : 50% (12 calls matureds) · 📊 on Health : 43.8% · -5.4% (105 calls)
-21.7%
stock +22% · XLV +20%
matured Jul 24, 26
▼ Underperform · 🎯$10
Price at call : $13.32 — upside -25%
Today : $21.59 — upside -54%
Expected -25% · Actual +19% · Reason (≤ −15%) : ✗ No
🎯 on SRPT : 42% (12 calls matureds) · 📊 on Health : 51.3% · +3.0% (152 calls)
-19.2%
stock +19% · XLV +18%
matured Jul 23, 26
BMO Capital 
Jul 22, 25
■ Market Perform neutral · not a buy · 🎯$25
Price at call : $13.32 — gap to target +88%
Today : $21.59 — gap to target +16%
🎯 on SRPT : no call matured yet · 📊 on Health : 43.9% · -2.1% (66 calls)
in progress (365j)
matures : Jul 22, 26
Piper Sandler 
Jul 22, 25
■ Neutral neutral · not a buy · 🎯$11
Price at call : $13.32 — gap to target -17%
Today : $21.59 — gap to target -49%
🎯 on SRPT : 8% (12 calls matureds) · 📊 on Health : 45.8% · +6.9% (249 calls)
in progress (365j)
matures : Jul 22, 26
Barclays 
Jul 22, 25
■ Equal-Weight neutral · not a buy · 🎯$18
Price at call : $13.62 — gap to target +32%
Today : $21.59 — gap to target -17%
🎯 on SRPT : 0% (1 call matured) · 📊 on Health : 37.3% · -8.4% (150 calls)
in progress (365j)
matures : Jul 22, 26
Needham 
Jul 22, 25
▼ Underperform
Actual +16% · Reason (≤ −15%) : ✗ No
🎯 on SRPT : 8% (12 calls matureds) · 📊 on Health : 39% · -2.9% (397 calls)
-16.2%
stock +16% · XLV +19%
matured Jul 22, 26
JP Morgan 
Jul 21, 25
▲ Overweight · 🎯$20
Price at call : $13.32 — upside +50%
Today : $21.59 — upside -7%
Expected +50% · Actual +22% · Reason (≥ +15%) : ✓ Yes
🎯 on SRPT : 50% (12 calls matureds) · 📊 on Health : 49.3% · +6.9% (146 calls)
+21.7%
stock +22% · XLV +22%
matured Jul 21, 26
Needham 
Jul 21, 25
▼ Underperform
Actual +22% · Reason (≤ −15%) : ✗ No
🎯 on SRPT : 8% (12 calls matureds) · 📊 on Health : 39% · -2.9% (397 calls)
-21.7%
stock +22% · XLV +22%
matured Jul 21, 26
Oppenheimer 
Jul 18, 25
▲ Outperform · 🎯$41
Price at call : $14.08 — upside +191%
Today : $21.59 — upside +90%
Expected +191% · Actual +20% · Reason (≥ +15%) : ✓ Yes
🎯 on SRPT : 36% (11 calls matureds) · 📊 on Health : 47.3% · +6.3% (93 calls)
+19.5%
stock +20% · XLV +21%
matured Jul 18, 26
Baird 
Jul 17, 25
▲ Outperform · 🎯$35
Price at call : $21.97 — upside +59%
Today : $21.59 — upside +62%
Expected +59% · Actual -22% · Reason (≥ +15%) : ✗ No
🎯 on SRPT : 27% (11 calls matureds) · 📊 on Health : 37.8% · -2.8% (82 calls)
-21.6%
stock -22% · XLV +21%
matured Jul 17, 26
Needham 
Jul 17, 25
▲ Buy · 🎯$50
Price at call : $21.97 — upside +128%
Today : $21.59 — upside +132%
Expected +128% · Actual -22% · Reason (≥ +15%) : ✗ No
🎯 on SRPT : 8% (12 calls matureds) · 📊 on Health : 39% · -2.9% (397 calls)
-21.6%
stock -22% · XLV +21%
matured Jul 17, 26
JP Morgan 
Jul 10, 25
▲ Overweight · 🎯$28
Price at call : $18.17 — upside +54%
Today : $21.59 — upside +30%
Expected +54% · Actual +4% · Reason (≥ +15%) : ✗ No
🎯 on SRPT : 50% (12 calls matureds) · 📊 on Health : 49.3% · +6.9% (146 calls)
+3.6%
stock +4% · XLV +19%
matured Jul 10, 26
▼ Sell · 🎯$10
Price at call : $17.46 — upside -43%
Today : $21.59 — upside -54%
Expected -43% · Actual -8% · Reason (≤ −15%) : ✗ No
🎯 on SRPT : 83% (12 calls matureds) · 📊 on Health : 57.9% · +25.9% (321 calls)
+8.3%
stock -8% · XLV +16%
matured Jun 25, 26
JP Morgan 
Jun 22, 25
▲ Overweight · 🎯$30
Price at call : $18.87 — upside +59%
Today : $21.59 — upside +39%
Expected +59% · Actual -9% · Reason (≥ +15%) : ✗ No
🎯 on SRPT : 50% (12 calls matureds) · 📊 on Health : 49.3% · +6.9% (146 calls)
-8.5%
stock -9% · XLV +15%
matured Jun 22, 26
Oppenheimer 
Jun 20, 25
▲ Outperform · 🎯$45
Price at call : $18.87 — upside +138%
Today : $21.59 — upside +108%
Expected +138% · Actual -6% · Reason (≥ +15%) : ✗ No
🎯 on SRPT : 36% (11 calls matureds) · 📊 on Health : 47.3% · +6.3% (93 calls)
-6.5%
stock -6% · XLV +14%
matured Jun 20, 26
William Blair 
Jun 20, 25
■ Market Perform neutral · not a buy
🎯 on SRPT : no call matured yet · 📊 on Health : 32% · -10.8% (25 calls)
in progress (365j)
matures : Jun 20, 26
Mizuho 
Jun 18, 25
▲ Outperform · 🎯$40
Price at call : $20.08 — upside +99%
Today : $21.59 — upside +85%
Expected +99% · Actual -12% · Reason (≥ +15%) : ✗ No
🎯 on SRPT : 22% (9 calls matureds) · 📊 on Health : 26.4% · -9.4% (87 calls)
-12.1%
stock -12% · XLV +13%
matured Jun 18, 26
Baird 
Jun 17, 25
▲ Outperform · 🎯$30
Price at call : $20.77 — upside +44%
Today : $21.59 — upside +39%
Expected +44% · Actual -16% · Reason (≥ +15%) : ✗ No
🎯 on SRPT : 27% (11 calls matureds) · 📊 on Health : 37.8% · -2.8% (82 calls)
-15.6%
stock -16% · XLV +12%
matured Jun 17, 26
Wolfe Research 
Jun 17, 25
■ Peer Perform neutral · not a buy
🎯 on SRPT : no call matured yet · 📊 overall : 35.2% · -2.7% (105 calls)
in progress (365j)
matures : Jun 17, 26
Needham 
Jun 16, 25
▲ Buy · 🎯$50
Price at call : $21.56 — upside +132%
Today : $21.59 — upside +132%
Expected +132% · Actual -21% · Reason (≥ +15%) : ✗ No
🎯 on SRPT : 8% (12 calls matureds) · 📊 on Health : 39% · -2.9% (397 calls)
-21.3%
stock -21% · XLV +13%
matured Jun 16, 26
▼ Sell · 🎯$10
Price at call : $20.94 — upside -52%
Today : $21.59 — upside -54%
Expected -52% · Actual -25% · Reason (≤ −15%) : ✓ Yes
🎯 on SRPT : 83% (12 calls matureds) · 📊 on Health : 57.9% · +25.9% (321 calls)
+24.6%
stock -25% · XLV +13%
matured Jun 16, 26
JP Morgan 
May 20, 25
▲ Overweight · 🎯$84
Price at call : $40.05 — upside +110%
Today : $21.59 — upside +289%
Expected +110% · Actual -58% · Reason (≥ +15%) : ✗ No
🎯 on SRPT : 50% (12 calls matureds) · 📊 on Health : 49.3% · +6.9% (146 calls)
-57.6%
stock -58% · XLV +13%
matured May 20, 26
Mizuho 
May 9, 25
▲ Outperform · 🎯$85
Price at call : $36.27 — upside +134%
Today : $21.59 — upside +294%
Expected +134% · Actual -47% · Reason (≥ +15%) : ✗ No
🎯 on SRPT : 22% (9 calls matureds) · 📊 on Health : 26.4% · -9.4% (87 calls)
-46.5%
stock -47% · XLV +8%
matured May 9, 26
Piper Sandler 
May 7, 25
▲ Overweight · 🎯$70
Price at call : $36.52 — upside +92%
Today : $21.59 — upside +224%
Expected +92% · Actual -45% · Reason (≥ +15%) : ✗ No
🎯 on SRPT : 8% (12 calls matureds) · 📊 on Health : 45.8% · +6.9% (249 calls)
-45.4%
stock -45% · XLV +7%
matured May 7, 26
Oppenheimer 
May 7, 25
▲ Outperform · 🎯$123
Price at call : $36.52 — upside +237%
Today : $21.59 — upside +470%
Expected +237% · Actual -45% · Reason (≥ +15%) : ✗ No
🎯 on SRPT : 36% (11 calls matureds) · 📊 on Health : 47.3% · +6.3% (93 calls)
-45.4%
stock -45% · XLV +7%
matured May 7, 26
▲ Overweight · 🎯$81
Price at call : $36.52 — upside +122%
Today : $21.59 — upside +275%
Expected +122% · Actual -45% · Reason (≥ +15%) : ✗ No
🎯 on SRPT : 36% (11 calls matureds) · 📊 on Health : 50.6% · +13.8% (166 calls)
-45.4%
stock -45% · XLV +7%
matured May 7, 26
▲ Overweight · 🎯$113
Price at call : $36.72 — upside +208%
Today : $21.59 — upside +423%
Expected +208% · Actual -43% · Reason (≥ +15%) : ✗ No
🎯 on SRPT : 42% (12 calls matureds) · 📊 on Health : 55.5% · +4.6% (182 calls)
-43.4%
stock -43% · XLV +7%
matured May 7, 26
Needham 
May 7, 25
▲ Buy · 🎯$125
Price at call : $36.72 — upside +240%
Today : $21.59 — upside +479%
Expected +240% · Actual -43% · Reason (≥ +15%) : ✗ No
🎯 on SRPT : 8% (12 calls matureds) · 📊 on Health : 39% · -2.9% (397 calls)
-43.4%
stock -43% · XLV +7%
matured May 7, 26
Baird 
May 7, 25
▲ Outperform · 🎯$60
Price at call : $36.72 — upside +63%
Today : $21.59 — upside +178%
Expected +63% · Actual -43% · Reason (≥ +15%) : ✗ No
🎯 on SRPT : 27% (11 calls matureds) · 📊 on Health : 37.8% · -2.8% (82 calls)
-43.4%
stock -43% · XLV +7%
matured May 7, 26
Piper Sandler 
Apr 21, 25
▲ Overweight · 🎯$110
Price at call : $59.31 — upside +85%
Today : $21.59 — upside +409%
Expected +85% · Actual -65% · Reason (≥ +15%) : ✗ No
🎯 on SRPT : 8% (12 calls matureds) · 📊 on Health : 45.8% · +6.9% (249 calls)
-65.2%
stock -65% · XLV +8%
matured Apr 21, 26
Morgan Stanley 
Apr 11, 25
▲ Overweight · 🎯$182
Price at call : $54.63 — upside +233%
Today : $21.59 — upside +743%
Expected +233% · Actual -60% · Reason (≥ +15%) : ✗ No
🎯 on SRPT : 42% (12 calls matureds) · 📊 on Health : 55.5% · +4.6% (182 calls)
-60.1%
stock -60% · XLV +7%
matured Apr 11, 26
Needham 
Apr 3, 25
▲ Buy · 🎯$183
Price at call : $58.61 — upside +212%
Today : $21.59 — upside +748%
Expected +212% · Actual -61% · Reason (≥ +15%) : ✗ No
🎯 on SRPT : 8% (12 calls matureds) · 📊 on Health : 39% · -2.9% (397 calls)
-61.1%
stock -61% · XLV +2%
matured Apr 3, 26
▲ Overweight · 🎯$163
Price at call : $73.45 — upside +122%
Today : $21.59 — upside +655%
Expected +122% · Actual -77% · Reason (≥ +15%) : ✗ No
🎯 on SRPT : 36% (11 calls matureds) · 📊 on Health : 50.6% · +13.8% (166 calls)
-77.3%
stock -77% · XLV -1%
matured Mar 19, 26
▼ Sell · 🎯$75
Price at call : $79.97 — upside -6%
Today : $21.59 — upside +247%
Expected -6% · Actual -79% · Reason (≤ −15%) : ✓ Yes
🎯 on SRPT : 83% (12 calls matureds) · 📊 on Health : 57.9% · +25.9% (321 calls)
+79.2%
stock -79% · XLV -0%
matured Mar 19, 26
Needham 
Mar 18, 25
▲ Buy · 🎯$202
Price at call : $79.97 — upside +153%
Today : $21.59 — upside +836%
Expected +153% · Actual -79% · Reason (≥ +15%) : ✗ No
🎯 on SRPT : 8% (12 calls matureds) · 📊 on Health : 39% · -2.9% (397 calls)
-79.2%
stock -79% · XLV -0%
matured Mar 18, 26
▲ Overweight · 🎯$163
Price at call : $73.54 — upside +122%
Today : $21.59 — upside +655%
Expected +122% · Actual -77% · Reason (≥ +15%) : ✗ No
🎯 on SRPT : 36% (11 calls matureds) · 📊 on Health : 50.6% · +13.8% (166 calls)
-76.7%
stock -77% · XLV +0%
matured Mar 18, 26
RBC Capital 
Feb 27, 25
▲ Outperform · 🎯$161
Price at call : $106.75 — upside +51%
Today : $21.59 — upside +646%
Expected +51% · Actual -85% · Reason (≥ +15%) : ✗ No
🎯 on SRPT : 17% (12 calls matureds) · 📊 on Health : 30.7% · -10.7% (166 calls)
-84.7%
stock -85% · XLV +6%
matured Feb 27, 26
Needham 
Feb 27, 25
▲ Buy · 🎯$202
Price at call : $103.06 — upside +96%
Today : $21.59 — upside +836%
Expected +96% · Actual -84% · Reason (≥ +15%) : ✗ No
🎯 on SRPT : 8% (12 calls matureds) · 📊 on Health : 39% · -2.9% (397 calls)
-83.7%
stock -84% · XLV +9%
matured Feb 27, 26
▼ Sell · 🎯$75
Price at call : $103.06 — upside -27%
Today : $21.59 — upside +247%
Expected -27% · Actual -84% · Reason (≤ −15%) : ✓ Yes
🎯 on SRPT : 83% (12 calls matureds) · 📊 on Health : 57.9% · +25.9% (321 calls)
+83.7%
stock -84% · XLV +9%
matured Feb 27, 26
▼ Sell · 🎯$75
Price at call : $109.46 — upside -31%
Today : $21.59 — upside +247%
Expected -31% · Actual -84% · Reason (≤ −15%) : ✓ Yes
🎯 on SRPT : 83% (12 calls matureds) · 📊 on Health : 57.9% · +25.9% (321 calls)
+83.8%
stock -84% · XLV +8%
matured Feb 13, 26
▼ Sell · 🎯$75
Price at call : $114.45 — upside -34%
Today : $21.59 — upside +247%
Expected -34% · Actual -82% · Reason (≤ −15%) : ✓ Yes
🎯 on SRPT : 83% (12 calls matureds) · 📊 on Health : 57.9% · +25.9% (321 calls)
+82.2%
stock -82% · XLV +5%
matured Jan 30, 26
Needham 
Jan 27, 25
▲ Buy · 🎯$202
Price at call : $117.51 — upside +72%
Today : $21.59 — upside +836%
Expected +72% · Actual -82% · Reason (≥ +15%) : ✗ No
🎯 on SRPT : 8% (12 calls matureds) · 📊 on Health : 39% · -2.9% (397 calls)
-81.9%
stock -82% · XLV +5%
matured Jan 27, 26
▼ Sell · 🎯$75
Price at call : $119.33 — upside -37%
Today : $21.59 — upside +247%
Expected -37% · Actual -82% · Reason (≤ −15%) : ✓ Yes
🎯 on SRPT : 83% (12 calls matureds) · 📊 on Health : 57.9% · +25.9% (321 calls)
+82.1%
stock -82% · XLV +12%
matured Jan 15, 26
Needham 
Jan 14, 25
▲ Buy · 🎯$202
Price at call : $118.83 — upside +70%
Today : $21.59 — upside +836%
Expected +70% · Actual -81% · Reason (≥ +15%) : ✗ No
🎯 on SRPT : 8% (12 calls matureds) · 📊 on Health : 39% · -2.9% (397 calls)
-80.8%
stock -81% · XLV +13%
matured Jan 14, 26
▼ Sell · 🎯$75
Price at call : $119.47 — upside -37%
Today : $21.59 — upside +247%
Expected -37% · Actual -82% · Reason (≤ −15%) : ✓ Yes
🎯 on SRPT : 83% (12 calls matureds) · 📊 on Health : 57.9% · +25.9% (321 calls)
+82.4%
stock -82% · XLV +14%
matured Dec 19, 25
▼ Sell · 🎯$75
Price at call : $126.01 — upside -40%
Today : $21.59 — upside +247%
Expected -40% · Actual -83% · Reason (≤ −15%) : ✓ Yes
🎯 on SRPT : 83% (12 calls matureds) · 📊 on Health : 57.9% · +25.9% (321 calls)
+82.7%
stock -83% · XLV +6%
matured Dec 3, 25
Piper Sandler 
Nov 27, 24
▲ Overweight · 🎯$182
Price at call : $133.34 — upside +36%
Today : $21.59 — upside +743%
Expected +36% · Actual -84% · Reason (≥ +15%) : ✗ No
🎯 on SRPT : 8% (12 calls matureds) · 📊 on Health : 45.8% · +6.9% (249 calls)
-84.0%
stock -84% · XLV +7%
matured Nov 27, 25
▼ Sell · 🎯$80
Price at call : $114.65 — upside -30%
Today : $21.59 — upside +271%
Expected -30% · Actual -83% · Reason (≤ −15%) : ✓ Yes
🎯 on SRPT : 83% (12 calls matureds) · 📊 on Health : 57.9% · +25.9% (321 calls)
+83.1%
stock -83% · XLV +9%
matured Nov 25, 25
Baird 
Nov 7, 24
▲ Outperform · 🎯$193
Price at call : $121.61 — upside +59%
Today : $21.59 — upside +794%
Expected +59% · Actual -86% · Reason (≥ +15%) : ✗ No
🎯 on SRPT : 27% (11 calls matureds) · 📊 on Health : 37.8% · -2.8% (82 calls)
-85.8%
stock -86% · XLV -2%
matured Nov 7, 25
▲ Outperform · 🎯$170
Price at call : $120.42 — upside +41%
Today : $21.59 — upside +687%
Expected +41% · Actual -85% · Reason (≥ +15%) : ✗ No
🎯 on SRPT : 0% (7 calls matureds) · 📊 on Health : 37.9% · -7.6% (29 calls)
-85.4%
stock -85% · XLV -2%
matured Nov 7, 25
▲ Overweight · 🎯$167
Price at call : $120.42 — upside +39%
Today : $21.59 — upside +674%
Expected +39% · Actual -85% · Reason (≥ +15%) : ✗ No
🎯 on SRPT : 36% (11 calls matureds) · 📊 on Health : 50.6% · +13.8% (166 calls)
-85.4%
stock -85% · XLV -2%
matured Nov 7, 25
RBC Capital 
Oct 21, 24
▲ Outperform · 🎯$182
Price at call : $128.42 — upside +42%
Today : $21.59 — upside +743%
Expected +42% · Actual -83% · Reason (≥ +15%) : ✗ No
🎯 on SRPT : 17% (12 calls matureds) · 📊 on Health : 30.7% · -10.7% (166 calls)
-82.5%
stock -83% · XLV -3%
matured Oct 21, 25
RBC Capital 
Oct 4, 24
▲ Outperform · 🎯$182
Price at call : $117.79 — upside +55%
Today : $21.59 — upside +743%
Expected +55% · Actual -80% · Reason (≥ +15%) : ✗ No
🎯 on SRPT : 17% (12 calls matureds) · 📊 on Health : 30.7% · -10.7% (166 calls)
-80.3%
stock -80% · XLV -5%
matured Oct 4, 25
RBC Capital 
Sep 19, 24
▲ Outperform · 🎯$181
Price at call : $127.21 — upside +42%
Today : $21.59 — upside +738%
Expected +42% · Actual -85% · Reason (≥ +15%) : ✗ No
🎯 on SRPT : 17% (12 calls matureds) · 📊 on Health : 30.7% · -10.7% (166 calls)
-85.3%
stock -85% · XLV -12%
matured Sep 19, 25
RBC Capital 
Sep 6, 24
▲ Outperform · 🎯$181
Price at call : $128.92 — upside +40%
Today : $21.59 — upside +738%
Expected +40% · Actual -86% · Reason (≥ +15%) : ✗ No
🎯 on SRPT : 17% (12 calls matureds) · 📊 on Health : 30.7% · -10.7% (166 calls)
-86.4%
stock -86% · XLV -10%
matured Sep 6, 25
RBC Capital 
Aug 15, 24
▲ Outperform · 🎯$181
Price at call : $133.46 — upside +36%
Today : $21.59 — upside +738%
Expected +36% · Actual -84% · Reason (≥ +15%) : ✗ No
🎯 on SRPT : 17% (12 calls matureds) · 📊 on Health : 30.7% · -10.7% (166 calls)
-84.3%
stock -84% · XLV -11%
matured Aug 15, 25
RBC Capital 
Aug 8, 24
▲ Outperform · 🎯$181
Price at call : $125.34 — upside +44%
Today : $21.59 — upside +738%
Expected +44% · Actual -86% · Reason (≥ +15%) : ✗ No
🎯 on SRPT : 17% (12 calls matureds) · 📊 on Health : 30.7% · -10.7% (166 calls)
-85.7%
stock -86% · XLV -13%
matured Aug 8, 25
▲ Outperform · 🎯$179
Price at call : $136.4 — upside +31%
Today : $21.59 — upside +729%
Expected +31% · Actual -87% · Reason (≥ +15%) : ✗ No
🎯 on SRPT : 0% (7 calls matureds) · 📊 on Health : 37.9% · -7.6% (29 calls)
-86.6%
stock -87% · XLV -13%
matured Aug 8, 25
Piper Sandler 
Aug 8, 24
▲ Overweight · 🎯$200
Price at call : $136.4 — upside +47%
Today : $21.59 — upside +826%
Expected +47% · Actual -87% · Reason (≥ +15%) : ✗ No
🎯 on SRPT : 8% (12 calls matureds) · 📊 on Health : 45.8% · +6.9% (249 calls)
-86.6%
stock -87% · XLV -13%
matured Aug 8, 25
RBC Capital 
Jul 29, 24
▲ Outperform · 🎯$182
Price at call : $146.03 — upside +25%
Today : $21.59 — upside +743%
Expected +25% · Actual -89% · Reason (≥ +15%) : ✗ No
🎯 on SRPT : 17% (12 calls matureds) · 📊 on Health : 30.7% · -10.7% (166 calls)
-89.2%
stock -89% · XLV -10%
matured Jul 29, 25
Piper Sandler 
Jul 1, 24
▲ Overweight · 🎯$205
Price at call : $154.2 — upside +33%
Today : $21.59 — upside +850%
Expected +33% · Actual -88% · Reason (≥ +15%) : ✗ No
🎯 on SRPT : 8% (12 calls matureds) · 📊 on Health : 45.8% · +6.9% (249 calls)
-88.2%
stock -88% · XLV -6%
matured Jul 1, 25
Morgan Stanley 
Jun 24, 24
▲ Overweight · 🎯$200
Price at call : $158.06 — upside +27%
Today : $21.59 — upside +826%
Expected +27% · Actual -89% · Reason (≥ +15%) : ✗ No
🎯 on SRPT : 42% (12 calls matureds) · 📊 on Health : 55.5% · +4.6% (182 calls)
-88.9%
stock -89% · XLV -9%
matured Jun 24, 25
▲ Outperform · 🎯$230
Price at call : $163.85 — upside +40%
Today : $21.59 — upside +965%
Expected +40% · Actual -88% · Reason (≥ +15%) : ✗ No
🎯 on SRPT : 0% (1 call matured) · 📊 on Health : 50% · -5.3% (10 calls)
-88.4%
stock -88% · XLV -9%
matured Jun 24, 25
Morgan Stanley 
Jun 21, 24
▲ Overweight · 🎯$165
Price at call : $163.85 — upside +1%
Today : $21.59 — upside +664%
Expected +1% · Actual -88% · Reason (≥ +15%) : ✗ No
🎯 on SRPT : 42% (12 calls matureds) · 📊 on Health : 55.5% · +4.6% (182 calls)
-88.5%
stock -88% · XLV -10%
matured Jun 21, 25
Piper Sandler 
Jun 21, 24
▲ Overweight · 🎯$157
Price at call : $163.85 — upside -4%
Today : $21.59 — upside +627%
Expected -4% · Actual -88% · Reason (≥ +15%) : ✗ No
🎯 on SRPT : 8% (12 calls matureds) · 📊 on Health : 45.8% · +6.9% (249 calls)
-88.5%
stock -88% · XLV -10%
matured Jun 21, 25
Baird 
Jun 21, 24
▲ Outperform · 🎯$200
Price at call : $160.72 — upside +24%
Today : $21.59 — upside +826%
Expected +24% · Actual -88% · Reason (≥ +15%) : ✗ No
🎯 on SRPT : 27% (11 calls matureds) · 📊 on Health : 37.8% · -2.8% (82 calls)
-88.3%
stock -88% · XLV -10%
matured Jun 21, 25
▲ Buy · 🎯$213
Price at call : $160.72 — upside +33%
Today : $21.59 — upside +887%
Expected +33% · Actual -88% · Reason (≥ +15%) : ✗ No
🎯 on SRPT : 42% (12 calls matureds) · 📊 on Health : 51.3% · +3.0% (152 calls)
-88.3%
stock -88% · XLV -10%
matured Jun 21, 25
Piper Sandler 
May 31, 24
▲ Overweight · 🎯$157
Price at call : $129.86 — upside +21%
Today : $21.59 — upside +627%
Expected +21% · Actual -71% · Reason (≥ +15%) : ✗ No
🎯 on SRPT : 8% (12 calls matureds) · 📊 on Health : 45.8% · +6.9% (249 calls)
-70.9%
stock -71% · XLV -8%
matured May 31, 25
Mizuho 
May 17, 24
▲ Buy · 🎯$179
Price at call : $131.38 — upside +36%
Today : $21.59 — upside +729%
Expected +36% · Actual -71% · Reason (≥ +15%) : ✗ No
🎯 on SRPT : 22% (9 calls matureds) · 📊 on Health : 26.4% · -9.4% (87 calls)
-71.1%
stock -71% · XLV -8%
matured May 17, 25
Oppenheimer 
May 14, 24
▲ Outperform · 🎯$180
Price at call : $132.66 — upside +36%
Today : $21.59 — upside +734%
Expected +36% · Actual -73% · Reason (≥ +15%) : ✗ No
🎯 on SRPT : 36% (11 calls matureds) · 📊 on Health : 47.3% · +6.3% (93 calls)
-73.1%
stock -73% · XLV -11%
matured May 14, 25
JP Morgan 
May 3, 24
▲ Overweight · 🎯$175
Price at call : $135.04 — upside +30%
Today : $21.59 — upside +711%
Expected +30% · Actual -53% · Reason (≥ +15%) : ✗ No
🎯 on SRPT : 50% (12 calls matureds) · 📊 on Health : 49.3% · +6.9% (146 calls)
-52.9%
stock -53% · XLV -2%
matured May 3, 25
RBC Capital 
Feb 29, 24
▲ Outperform · 🎯$157
Price at call : $128.67 — upside +22%
Today : $21.59 — upside +627%
Expected +22% · Actual -21% · Reason (≥ +15%) : ✗ No
🎯 on SRPT : 17% (12 calls matureds) · 📊 on Health : 30.7% · -10.7% (166 calls)
-21.3%
stock -21% · XLV +2%
matured Feb 28, 25
Citigroup 
Feb 29, 24
▲ Buy · 🎯$172
Price at call : $128.67 — upside +34%
Today : $21.59 — upside +697%
Expected +34% · Actual -21% · Reason (≥ +15%) : ✗ No
🎯 on SRPT : 50% (12 calls matureds) · 📊 on Health : 43.8% · -5.4% (105 calls)
-21.3%
stock -21% · XLV +2%
matured Feb 28, 25
Wedbush 
Feb 20, 24
▲ Outperform · 🎯$224
Price at call : $136.14 — upside +65%
Today : $21.59 — upside +938%
Expected +65% · Actual -21% · Reason (≥ +15%) : ✗ No
🎯 on SRPT : 82% (11 calls matureds) · 📊 on Health : 35.8% · +3.2% (53 calls)
-21.3%
stock -21% · XLV +1%
matured Feb 19, 25
Mizuho 
Feb 14, 24
▲ Buy · 🎯$145
Price at call : $124.89 — upside +16%
Today : $21.59 — upside +572%
Expected +16% · Actual -14% · Reason (≥ +15%) : ✗ No
🎯 on SRPT : 22% (9 calls matureds) · 📊 on Health : 26.4% · -9.4% (87 calls)
-13.6%
stock -14% · XLV -0%
matured Feb 13, 25
Wedbush 
Jan 30, 24
▲ Outperform · 🎯$224
Price at call : $118.99 — upside +88%
Today : $21.59 — upside +938%
Expected +88% · Actual -4% · Reason (≥ +15%) : ✗ No
🎯 on SRPT : 82% (11 calls matureds) · 📊 on Health : 35.8% · +3.2% (53 calls)
-3.8%
stock -4% · XLV +5%
matured Jan 29, 25
RBC Capital 
Jan 25, 24
▲ Outperform · 🎯$151
Price at call : $118.73 — upside +27%
Today : $21.59 — upside +599%
Expected +27% · Actual -2% · Reason (≥ +15%) : ✗ No
🎯 on SRPT : 17% (12 calls matureds) · 📊 on Health : 30.7% · -10.7% (166 calls)
-1.6%
stock -2% · XLV +6%
matured Jan 24, 25
Wedbush 
Jan 9, 24
▲ Outperform · 🎯$224
Price at call : $119.19 — upside +88%
Today : $21.59 — upside +938%
Expected +88% · Actual +5% · Reason (≥ +15%) : ✗ No
🎯 on SRPT : 82% (11 calls matureds) · 📊 on Health : 35.8% · +3.2% (53 calls)
+4.7%
stock +5% · XLV -1%
matured Jan 8, 25
Citigroup 
Dec 13, 23
▲ Buy · 🎯$113
Price at call : $92.11 — upside +23%
Today : $21.59 — upside +423%
Expected +23% · Actual +35% · Reason (≥ +15%) : ✓ Yes
🎯 on SRPT : 50% (12 calls matureds) · 📊 on Health : 43.8% · -5.4% (105 calls)
+35.1%
stock +35% · XLV +4%
matured Dec 12, 24
RBC Capital 
Nov 21, 23
▲ Outperform · 🎯$148
Price at call : $83.77 — upside +77%
Today : $21.59 — upside +586%
Expected +77% · Actual +32% · Reason (≥ +15%) : ✓ Yes
🎯 on SRPT : 17% (12 calls matureds) · 📊 on Health : 30.7% · -10.7% (166 calls)
+31.9%
stock +32% · XLV +10%
matured Nov 20, 24
Wedbush 
Nov 21, 23
▲ Outperform · 🎯$224
Price at call : $84.08 — upside +166%
Today : $21.59 — upside +938%
Expected +166% · Actual +32% · Reason (≥ +15%) : ✓ Yes
🎯 on SRPT : 82% (11 calls matureds) · 📊 on Health : 35.8% · +3.2% (53 calls)
+31.9%
stock +32% · XLV +10%
matured Nov 20, 24
JP Morgan 
Oct 31, 23
▲ Overweight · 🎯$115
Price at call : $76.52 — upside +50%
Today : $21.59 — upside +433%
Expected +50% · Actual +65% · Reason (≥ +15%) : ✓ Yes
🎯 on SRPT : 50% (12 calls matureds) · 📊 on Health : 49.3% · +6.9% (146 calls)
+64.7%
stock +65% · XLV +18%
matured Oct 30, 24
RBC Capital 
Oct 31, 23
▲ Outperform · 🎯$148
Price at call : $76.52 — upside +93%
Today : $21.59 — upside +586%
Expected +93% · Actual +65% · Reason (≥ +15%) : ✓ Yes
🎯 on SRPT : 17% (12 calls matureds) · 📊 on Health : 30.7% · -10.7% (166 calls)
+64.7%
stock +65% · XLV +18%
matured Oct 30, 24
Morgan Stanley 
Oct 31, 23
▲ Overweight · 🎯$146
Price at call : $67.31 — upside +117%
Today : $21.59 — upside +576%
Expected +117% · Actual +90% · Reason (≥ +15%) : ✓ Yes
🎯 on SRPT : 42% (12 calls matureds) · 📊 on Health : 55.5% · +4.6% (182 calls)
+89.8%
stock +90% · XLV +19%
matured Oct 30, 24
Mizuho 
Sep 26, 23
▲ Buy · 🎯$160
Price at call : $119.41 — upside +34%
Today : $21.59 — upside +641%
Expected +34% · Actual +4% · Reason (≥ +15%) : ✗ No
🎯 on SRPT : 22% (9 calls matureds) · 📊 on Health : 26.4% · -9.4% (87 calls)
+4.4%
stock +4% · XLV +18%
matured Sep 25, 24
▲ Overweight · 🎯$183
Price at call : $105.31 — upside +74%
Today : $21.59 — upside +748%
Expected +74% · Actual +34% · Reason (≥ +15%) : ✓ Yes
🎯 on SRPT : 42% (12 calls matureds) · 📊 on Health : 55.5% · +4.6% (182 calls)
+33.6%
stock +34% · XLV +11%
matured Aug 2, 24
Morgan Stanley 
Jul 14, 23
▲ Overweight · 🎯$183
Price at call : $107.29 — upside +71%
Today : $21.59 — upside +748%
Expected +71% · Actual +42% · Reason (≥ +15%) : ✓ Yes
🎯 on SRPT : 42% (12 calls matureds) · 📊 on Health : 55.5% · +4.6% (182 calls)
+42.3%
stock +42% · XLV +13%
matured Jul 13, 24
▲ Overweight · 🎯$166
Price at call : $108.28 — upside +53%
Today : $21.59 — upside +669%
Expected +53% · Actual +51% · Reason (≥ +15%) : ✓ Yes
🎯 on SRPT : 36% (11 calls matureds) · 📊 on Health : 50.6% · +13.8% (166 calls)
+51.3%
stock +51% · XLV +12%
matured Jun 22, 24
Citigroup 
Jun 23, 23
▲ Buy · 🎯$161
Price at call : $108.28 — upside +49%
Today : $21.59 — upside +646%
Expected +49% · Actual +51% · Reason (≥ +15%) : ✓ Yes
🎯 on SRPT : 50% (12 calls matureds) · 📊 on Health : 43.8% · -5.4% (105 calls)
+51.3%
stock +51% · XLV +12%
matured Jun 22, 24
JP Morgan 
Jun 23, 23
▲ Overweight · 🎯$213
Price at call : $108.28 — upside +97%
Today : $21.59 — upside +887%
Expected +97% · Actual +51% · Reason (≥ +15%) : ✓ Yes
🎯 on SRPT : 50% (12 calls matureds) · 📊 on Health : 49.3% · +6.9% (146 calls)
+51.3%
stock +51% · XLV +12%
matured Jun 22, 24
Morgan Stanley 
Jun 23, 23
▲ Overweight · 🎯$183
Price at call : $108.28 — upside +69%
Today : $21.59 — upside +748%
Expected +69% · Actual +51% · Reason (≥ +15%) : ✓ Yes
🎯 on SRPT : 42% (12 calls matureds) · 📊 on Health : 55.5% · +4.6% (182 calls)
+51.3%
stock +51% · XLV +12%
matured Jun 22, 24
▲ Outperform · 🎯$151
Price at call : $124.82 — upside +21%
Today : $21.59 — upside +599%
Expected +21% · Actual -7% · Reason (≥ +15%) : ✗ No
🎯 on SRPT : 0% (7 calls matureds) · 📊 on Health : 37.9% · -7.6% (29 calls)
-6.9%
stock -7% · XLV +12%
matured May 29, 24
Oppenheimer 
May 26, 23
▲ Outperform · 🎯$180
Price at call : $124.82 — upside +44%
Today : $21.59 — upside +734%
Expected +44% · Actual -9% · Reason (≥ +15%) : ✗ No
🎯 on SRPT : 36% (11 calls matureds) · 📊 on Health : 47.3% · +6.3% (93 calls)
-9.2%
stock -9% · XLV +13%
matured May 25, 24
▲ Buy · 🎯$176
Price at call : $157.19 — upside +12%
Today : $21.59 — upside +715%
Expected +12% · Actual -16% · Reason (≥ +15%) : ✗ No
🎯 on SRPT : 42% (12 calls matureds) · 📊 on Health : 51.3% · +3.0% (152 calls)
-15.6%
stock -16% · XLV +9%
matured May 14, 24
▲ Outperform · 🎯$173
Price at call : $157.19 — upside +10%
Today : $21.59 — upside +701%
Expected +10% · Actual -16% · Reason (≥ +15%) : ✗ No
🎯 on SRPT : 0% (7 calls matureds) · 📊 on Health : 37.9% · -7.6% (29 calls)
-15.6%
stock -16% · XLV +9%
matured May 14, 24
▲ Buy · 🎯$164
Price at call : $121.27 — upside +35%
Today : $21.59 — upside +660%
Expected +35% · Actual +9% · Reason (≥ +15%) : ✗ No
🎯 on SRPT : 42% (12 calls matureds) · 📊 on Health : 51.3% · +3.0% (152 calls)
+9.1%
stock +9% · XLV +8%
matured May 9, 24
▲ Overweight · 🎯$158
Price at call : $125.43 — upside +26%
Today : $21.59 — upside +632%
Expected +26% · Actual +4% · Reason (≥ +15%) : ✗ No
🎯 on SRPT : 36% (11 calls matureds) · 📊 on Health : 50.6% · +13.8% (166 calls)
+4.2%
stock +4% · XLV +5%
matured May 2, 24
Mizuho 
Apr 14, 23
▲ Buy · 🎯$160
Price at call : $122.63 — upside +30%
Today : $21.59 — upside +641%
Expected +30% · Actual -4% · Reason (≥ +15%) : ✗ No
🎯 on SRPT : 22% (9 calls matureds) · 📊 on Health : 26.4% · -9.4% (87 calls)
-3.5%
stock -4% · XLV +3%
matured Apr 13, 24
▲ Buy · 🎯$164
Price at call : $122.63 — upside +34%
Today : $21.59 — upside +660%
Expected +34% · Actual -4% · Reason (≥ +15%) : ✗ No
🎯 on SRPT : 42% (12 calls matureds) · 📊 on Health : 51.3% · +3.0% (152 calls)
-3.5%
stock -4% · XLV +3%
matured Apr 13, 24
▲ Outperform · 🎯$149
Price at call : $124.72 — upside +19%
Today : $21.59 — upside +590%
Expected +19% · Actual -1% · Reason (≥ +15%) : ✗ No
🎯 on SRPT : 0% (7 calls matureds) · 📊 on Health : 37.9% · -7.6% (29 calls)
-1.5%
stock -1% · XLV +2%
matured Apr 12, 24
Citigroup 
Apr 4, 23
▲ Buy · 🎯$179
Price at call : $138.58 — upside +29%
Today : $21.59 — upside +729%
Expected +29% · Actual -8% · Reason (≥ +15%) : ✗ No
🎯 on SRPT : 50% (12 calls matureds) · 📊 on Health : 43.8% · -5.4% (105 calls)
-8.4%
stock -8% · XLV +10%
matured Apr 3, 24
▲ Buy · 🎯$164
Price at call : $131.38 — upside +25%
Today : $21.59 — upside +660%
Expected +25% · Actual -6% · Reason (≥ +15%) : ✗ No
🎯 on SRPT : 42% (12 calls matureds) · 📊 on Health : 51.3% · +3.0% (152 calls)
-5.6%
stock -6% · XLV +15%
matured Mar 19, 24
Mizuho 
Mar 17, 23
▲ Buy · 🎯$160
Price at call : $122.69 — upside +30%
Today : $21.59 — upside +641%
Expected +30% · Actual +1% · Reason (≥ +15%) : ✗ No
🎯 on SRPT : 22% (9 calls matureds) · 📊 on Health : 26.4% · -9.4% (87 calls)
+1.0%
stock +1% · XLV +15%
matured Mar 16, 24
▲ Buy · 🎯$164
Price at call : $122.69 — upside +34%
Today : $21.59 — upside +660%
Expected +34% · Actual +1% · Reason (≥ +15%) : ✗ No
🎯 on SRPT : 42% (12 calls matureds) · 📊 on Health : 51.3% · +3.0% (152 calls)
+1.0%
stock +1% · XLV +15%
matured Mar 16, 24
Oppenheimer 
Mar 9, 23
▲ Outperform · 🎯$150
Price at call : $148.44 — upside +1%
Today : $21.59 — upside +595%
Expected +1% · Actual -16% · Reason (≥ +15%) : ✗ No
🎯 on SRPT : 36% (11 calls matureds) · 📊 on Health : 47.3% · +6.3% (93 calls)
-16.2%
stock -16% · XLV +17%
matured Mar 8, 24
JP Morgan 
Mar 3, 23
▲ Overweight · 🎯$206
Price at call : $155.61 — upside +32%
Today : $21.59 — upside +854%
Expected +32% · Actual -20% · Reason (≥ +15%) : ✗ No
🎯 on SRPT : 50% (12 calls matureds) · 📊 on Health : 49.3% · +6.9% (146 calls)
-20.4%
stock -20% · XLV +13%
matured Mar 2, 24
Baird 
Mar 1, 23
▲ Outperform · 🎯$202
Price at call : $153 — upside +32%
Today : $21.59 — upside +836%
Expected +32% · Actual -16% · Reason (≥ +15%) : ✗ No
🎯 on SRPT : 27% (11 calls matureds) · 📊 on Health : 37.8% · -2.8% (82 calls)
-15.9%
stock -16% · XLV +15%
matured Feb 29, 24
Oppenheimer 
Mar 1, 23
▲ Outperform · 🎯$180
Price at call : $145.63 — upside +24%
Today : $21.59 — upside +734%
Expected +24% · Actual -12% · Reason (≥ +15%) : ✗ No
🎯 on SRPT : 36% (11 calls matureds) · 📊 on Health : 47.3% · +6.3% (93 calls)
-12.2%
stock -12% · XLV +14%
matured Feb 29, 24
▲ Outperform · 🎯$171
Price at call : $145.63 — upside +17%
Today : $21.59 — upside +692%
Expected +17% · Actual -12% · Reason (≥ +15%) : ✗ No
🎯 on SRPT : 0% (7 calls matureds) · 📊 on Health : 37.9% · -7.6% (29 calls)
-12.2%
stock -12% · XLV +14%
matured Feb 29, 24
▲ Overweight · 🎯$187
Price at call : $145.63 — upside +28%
Today : $21.59 — upside +766%
Expected +28% · Actual -12% · Reason (≥ +15%) : ✗ No
🎯 on SRPT : 42% (12 calls matureds) · 📊 on Health : 55.5% · +4.6% (182 calls)
-12.2%
stock -12% · XLV +14%
matured Feb 29, 24
▲ Buy · 🎯$160
Price at call : $122.13 — upside +31%
Today : $21.59 — upside +641%
Expected +31% · Actual +13% · Reason (≥ +15%) : ✗ No
🎯 on SRPT : 42% (12 calls matureds) · 📊 on Health : 51.3% · +3.0% (152 calls)
+12.6%
stock +13% · XLV +15%
matured Feb 28, 24
▲ Buy · 🎯$138
Price at call : $117.1 — upside +18%
Today : $21.59 — upside +539%
Expected +18% · Actual -31% · Reason (≥ +15%) : ✗ No
🎯 on SRPT : 42% (12 calls matureds) · 📊 on Health : 51.3% · +3.0% (152 calls)
-31.3%
stock -31% · XLV -4%
matured Nov 29, 23
▲ Buy · 🎯$129
Price at call : $105.01 — upside +23%
Today : $21.59 — upside +497%
Expected +23% · Actual -26% · Reason (≥ +15%) : ✗ No
🎯 on SRPT : 42% (12 calls matureds) · 📊 on Health : 51.3% · +3.0% (152 calls)
-25.7%
stock -26% · XLV -2%
matured Nov 3, 23
▲ Overweight · 🎯$128
Price at call : $76.3 — upside +68%
Today : $21.59 — upside +493%
Expected +68% · Actual +42% · Reason (≥ +15%) : ✓ Yes
🎯 on SRPT : 36% (11 calls matureds) · 📊 on Health : 50.6% · +13.8% (166 calls)
+41.9%
stock +42% · XLV +1%
matured Jun 24, 23
Oppenheimer 
Dec 9, 21
▲ Outperform · 🎯$125
Price at call : $85.46 — upside +46%
Today : $21.59 — upside +479%
Expected +46% · Actual +39% · Reason (≥ +15%) : ✓ Yes
🎯 on SRPT : 36% (11 calls matureds) · 📊 on Health : 47.3% · +6.3% (93 calls)
+38.5%
stock +39% · XLV +3%
matured Dec 9, 22
JP Morgan 
Nov 5, 21
▲ Overweight · 🎯$130
Price at call : $88.93 — upside +46%
Today : $21.59 — upside +502%
Expected +46% · Actual +13% · Reason (≥ +15%) : ✗ No
🎯 on SRPT : 50% (12 calls matureds) · 📊 on Health : 49.3% · +6.9% (146 calls)
+12.9%
stock +13% · XLV -0%
matured Nov 5, 22
Mizuho 
Feb 26, 21
▲ Buy · 🎯$160
Price at call : $87.03 — upside +84%
Today : $21.59 — upside +641%
Expected +84% · Actual -12% · Reason (≥ +15%) : ✗ No
🎯 on SRPT : 22% (9 calls matureds) · 📊 on Health : 26.4% · -9.4% (87 calls)
-12.0%
stock -12% · XLV +14%
matured Feb 26, 22
JP Morgan 
Jan 8, 21
▼ Underweight · 🎯$96
Price at call : $82.29 — upside +17%
Today : $21.59 — upside +345%
Expected +17% · Actual -7% · Reason (≤ −15%) : ✗ No
🎯 on SRPT : 50% (12 calls matureds) · 📊 on Health : 49.3% · +6.9% (146 calls)
+7.5%
stock -7% · XLV +16%
matured Jan 8, 22
Citigroup 
Sep 15, 20
▲ Buy · 🎯$190
Price at call : $143.95 — upside +32%
Today : $21.59 — upside +780%
Expected +32% · Actual -41% · Reason (≥ +15%) : ✗ No
🎯 on SRPT : 50% (12 calls matureds) · 📊 on Health : 43.8% · -5.4% (105 calls)
-40.5%
stock -41% · XLV +25%
matured Sep 15, 21
▲ Buy · 🎯$221
Price at call : $146.42 — upside +51%
Today : $21.59 — upside +924%
Expected +51% · Actual -47% · Reason (≥ +15%) : ✗ No
🎯 on SRPT : 83% (12 calls matureds) · 📊 on Health : 57.9% · +25.9% (321 calls)
-46.7%
stock -47% · XLV +25%
matured Aug 31, 21
Morgan Stanley 
Aug 10, 20
▲ Overweight · 🎯$182
Price at call : $159 — upside +14%
Today : $21.59 — upside +743%
Expected +14% · Actual -50% · Reason (≥ +15%) : ✗ No
🎯 on SRPT : 42% (12 calls matureds) · 📊 on Health : 55.5% · +4.6% (182 calls)
-50.0%
stock -50% · XLV +26%
matured Aug 10, 21
Morgan Stanley 
Apr 15, 20
▲ Overweight · 🎯$172
Price at call : $112.74 — upside +53%
Today : $21.59 — upside +697%
Expected +53% · Actual -36% · Reason (≥ +15%) : ✗ No
🎯 on SRPT : 42% (12 calls matureds) · 📊 on Health : 55.5% · +4.6% (182 calls)
-36.3%
stock -36% · XLV +23%
matured Apr 15, 21
Mizuho 
Mar 31, 20
▲ Buy · 🎯$183
Price at call : $97.82 — upside +87%
Today : $21.59 — upside +748%
Expected +87% · Actual -24% · Reason (≥ +15%) : ✗ No
🎯 on SRPT : 22% (9 calls matureds) · 📊 on Health : 26.4% · -9.4% (87 calls)
-23.8%
stock -24% · XLV +32%
matured Mar 31, 21
JP Morgan 
Feb 28, 20
▲ Overweight · 🎯$160
Price at call : $119.86 — upside +33%
Today : $21.59 — upside +641%
Expected +33% · Actual -27% · Reason (≥ +15%) : ✗ No
🎯 on SRPT : 50% (12 calls matureds) · 📊 on Health : 49.3% · +6.9% (146 calls)
-27.4%
stock -27% · XLV +18%
matured Feb 27, 21
▲ Overweight · 🎯$217
Price at call : $107.67 — upside +102%
Today : $21.59 — upside +905%
Expected +102% · Actual -19% · Reason (≥ +15%) : ✗ No
🎯 on SRPT : 36% (11 calls matureds) · 📊 on Health : 50.6% · +13.8% (166 calls)
-19.1%
stock -19% · XLV +20%
matured Feb 26, 21
Morgan Stanley 
Dec 24, 19
▲ Overweight · 🎯$173
Price at call : $134.3 — upside +29%
Today : $21.59 — upside +701%
Expected +29% · Actual +33% · Reason (≥ +15%) : ✓ Yes
🎯 on SRPT : 42% (12 calls matureds) · 📊 on Health : 55.5% · +4.6% (182 calls)
+32.6%
stock +33% · XLV +8%
matured Dec 23, 20
Baird 
Dec 20, 19
▲ Outperform · 🎯$192
Price at call : $135.58 — upside +42%
Today : $21.59 — upside +789%
Expected +42% · Actual +31% · Reason (≥ +15%) : ✓ Yes
🎯 on SRPT : 27% (11 calls matureds) · 📊 on Health : 37.8% · -2.8% (82 calls)
+30.6%
stock +31% · XLV +8%
matured Dec 19, 20
▲ Overweight · 🎯$211
Price at call : $135.35 — upside +56%
Today : $21.59 — upside +877%
Expected +56% · Actual +25% · Reason (≥ +15%) : ✓ Yes
🎯 on SRPT : 36% (11 calls matureds) · 📊 on Health : 50.6% · +13.8% (166 calls)
+25.3%
stock +25% · XLV +9%
matured Dec 12, 20
Piper Sandler 
Dec 13, 19
▲ Overweight · 🎯$210
Price at call : $135.35 — upside +55%
Today : $21.59 — upside +873%
Expected +55% · Actual +25% · Reason (≥ +15%) : ✓ Yes
🎯 on SRPT : 8% (12 calls matureds) · 📊 on Health : 45.8% · +6.9% (249 calls)
+25.3%
stock +25% · XLV +9%
matured Dec 12, 20
▲ Buy · 🎯$175
Price at call : $132.05 — upside +33%
Today : $21.59 — upside +711%
Expected +33% · Actual +28% · Reason (≥ +15%) : ✓ Yes
🎯 on SRPT : 60% (5 calls matureds) · 📊 on Health : 69.2% · +28.1% (13 calls)
+28.4%
stock +28% · XLV +10%
matured Dec 12, 20
Citigroup 
Nov 18, 19
▲ Buy · 🎯$167
Price at call : $97.9 — upside +71%
Today : $21.59 — upside +674%
Expected +71% · Actual +43% · Reason (≥ +15%) : ✓ Yes
🎯 on SRPT : 50% (12 calls matureds) · 📊 on Health : 43.8% · -5.4% (105 calls)
+42.8%
stock +43% · XLV +14%
matured Nov 17, 20
Citigroup 
Sep 27, 19
▲ Buy · 🎯$180
Price at call : $75 — upside +140%
Today : $21.59 — upside +734%
Expected +140% · Actual +91% · Reason (≥ +15%) : ✓ Yes
🎯 on SRPT : 50% (12 calls matureds) · 📊 on Health : 43.8% · -5.4% (105 calls)
+90.9%
stock +91% · XLV +16%
matured Sep 26, 20
Baird 
Aug 20, 19
▲ Outperform · 🎯$181
Price at call : $102.07 — upside +77%
Today : $21.59 — upside +738%
Expected +77% · Actual +46% · Reason (≥ +15%) : ✓ Yes
🎯 on SRPT : 27% (11 calls matureds) · 📊 on Health : 37.8% · -2.8% (82 calls)
+45.6%
stock +46% · XLV +18%
matured Aug 19, 20
▲ Buy · 🎯$175
Price at call : $102.07 — upside +71%
Today : $21.59 — upside +711%
Expected +71% · Actual +46% · Reason (≥ +15%) : ✓ Yes
🎯 on SRPT : 60% (5 calls matureds) · 📊 on Health : 69.2% · +28.1% (13 calls)
+45.6%
stock +46% · XLV +18%
matured Aug 19, 20
Citigroup 
May 16, 19
▲ Buy · 🎯$190
Price at call : $122.62 — upside +55%
Today : $21.59 — upside +780%
Expected +55% · Actual +15% · Reason (≥ +15%) : ✓ Yes
🎯 on SRPT : 50% (12 calls matureds) · 📊 on Health : 43.8% · -5.4% (105 calls)
+15.2%
stock +15% · XLV +13%
matured May 15, 20
▲ Outperform · 🎯$175
Price at call : $117.49 — upside +49%
Today : $21.59 — upside +711%
Expected +49% · Actual -5% · Reason (≥ +15%) : ✗ No
🎯 on SRPT : 0% (7 calls matureds) · 📊 on Health : 37.9% · -7.6% (29 calls)
-5.0%
stock -5% · XLV +5%
matured Apr 11, 20
Citigroup 
Mar 1, 19
▲ Buy · 🎯$201
Price at call : $146.69 — upside +37%
Today : $21.59 — upside +831%
Expected +37% · Actual -18% · Reason (≥ +15%) : ✗ No
🎯 on SRPT : 50% (12 calls matureds) · 📊 on Health : 43.8% · -5.4% (105 calls)
-18.3%
stock -18% · XLV +4%
matured Feb 29, 20
▲ Overweight · 🎯$231
Price at call : $146.69 — upside +57%
Today : $21.59 — upside +970%
Expected +57% · Actual -18% · Reason (≥ +15%) : ✗ No
🎯 on SRPT : 36% (11 calls matureds) · 📊 on Health : 50.6% · +13.8% (166 calls)
-18.3%
stock -18% · XLV +4%
matured Feb 28, 20
Citigroup 
Nov 6, 18
▲ Buy · 🎯$188
Price at call : $144.06 — upside +31%
Today : $21.59 — upside +771%
Expected +31% · Actual -35% · Reason (≥ +15%) : ✗ No
🎯 on SRPT : 50% (12 calls matureds) · 📊 on Health : 43.8% · -5.4% (105 calls)
-35.2%
stock -35% · XLV +1%
matured Nov 6, 19
▲ Overweight · 🎯$217
Price at call : $148.76 — upside +46%
Today : $21.59 — upside +905%
Expected +46% · Actual -49% · Reason (≥ +15%) : ✗ No
🎯 on SRPT : 36% (11 calls matureds) · 📊 on Health : 50.6% · +13.8% (166 calls)
-48.5%
stock -49% · XLV -7%
matured Oct 1, 19
Baird 
Jun 21, 18
▲ Outperform · 🎯$202
Price at call : $149.65 — upside +35%
Today : $21.59 — upside +836%
Expected +35% · Actual -13% · Reason (≥ +15%) : ✗ No
🎯 on SRPT : 27% (11 calls matureds) · 📊 on Health : 37.8% · -2.8% (82 calls)
-13.2%
stock -13% · XLV +11%
matured Jun 21, 19
▲ Buy · 🎯$75
Price at call : $57.81 — upside +30%
Today : $21.59 — upside +247%
Expected +30% · Actual +100% · Reason (≥ +15%) : ✓ Yes
🎯 on SRPT : 60% (5 calls matureds) · 📊 on Health : 69.2% · +28.1% (13 calls)
+99.7%
stock +100% · XLV +2%
matured Jan 4, 19
Piper Sandler 
Sep 19, 16
▲ Overweight
Actual -16% · Reason (≥ +15%) : ✗ No
🎯 on SRPT : 8% (12 calls matureds) · 📊 on Health : 45.8% · +6.9% (249 calls)
-16.2%
stock -16% · XLV +14%
matured Sep 19, 17
▲ Buy
Actual -16% · Reason (≥ +15%) : ✗ No
🎯 on SRPT : 60% (5 calls matureds) · 📊 on Health : 69.2% · +28.1% (13 calls)
-16.2%
stock -16% · XLV +14%
matured Sep 19, 17
Wedbush 
Jul 20, 16
▲ Outperform · 🎯$36
Price at call : $22.46 — upside +60%
Today : $21.59 — upside +67%
Expected +60% · Actual +82% · Reason (≥ +15%) : ✓ Yes
🎯 on SRPT : 82% (11 calls matureds) · 📊 on Health : 35.8% · +3.2% (53 calls)
+82.2%
stock +82% · XLV +9%
matured Jul 20, 17
Wedbush 
Jun 7, 16
▲ Outperform · 🎯$36
Price at call : $19.67 — upside +83%
Today : $21.59 — upside +67%
Expected +83% · Actual +60% · Reason (≥ +15%) : ✓ Yes
🎯 on SRPT : 82% (11 calls matureds) · 📊 on Health : 35.8% · +3.2% (53 calls)
+59.6%
stock +60% · XLV +7%
matured Jun 7, 17
Oppenheimer 
May 2, 16
▲ Outperform
Actual +100% · Reason (≥ +15%) : ✓ Yes
🎯 on SRPT : 36% (11 calls matureds) · 📊 on Health : 47.3% · +6.3% (93 calls)
+100.1%
stock +100% · XLV +8%
matured May 2, 17
Oppenheimer 
Apr 6, 16
▲ Outperform · 🎯$60
Price at call : $23.28 — upside +158%
Today : $21.59 — upside +178%
Expected +158% · Actual +23% · Reason (≥ +15%) : ✓ Yes
🎯 on SRPT : 36% (11 calls matureds) · 📊 on Health : 47.3% · +6.3% (93 calls)
+23.4%
stock +23% · XLV +7%
matured Apr 6, 17
Wedbush 
Oct 2, 15
▲ Outperform · 🎯$56
Price at call : $39.59 — upside +41%
Today : $21.59 — upside +159%
Expected +41% · Actual +54% · Reason (≥ +15%) : ✓ Yes
🎯 on SRPT : 82% (11 calls matureds) · 📊 on Health : 35.8% · +3.2% (53 calls)
+53.9%
stock +54% · XLV +6%
matured Oct 1, 16
Piper Sandler 
Aug 24, 15
▲ Overweight · 🎯$48
Price at call : $32.88 — upside +46%
Today : $21.59 — upside +122%
Expected +46% · Actual -20% · Reason (≥ +15%) : ✗ No
🎯 on SRPT : 8% (12 calls matureds) · 📊 on Health : 45.8% · +6.9% (249 calls)
-20.2%
stock -20% · XLV +9%
matured Aug 23, 16
Baird 
May 6, 15
▲ Outperform
Actual +14% · Reason (≥ +15%) : ✗ No
🎯 on SRPT : 27% (11 calls matureds) · 📊 on Health : 37.8% · -2.8% (82 calls)
+13.6%
stock +14% · XLV -3%
matured May 5, 16
Citigroup 
Jan 6, 14
▼ Sell · 🎯$13
Price at call : $18.77 — upside -31%
Today : $21.59 — upside -40%
Expected -31% · Actual -25% · Reason (≤ −15%) : ✓ Yes
🎯 on SRPT : 50% (12 calls matureds) · 📊 on Health : 43.8% · -5.4% (105 calls)
+24.8%
stock -25% · XLV +24%
matured Jan 6, 15
Wedbush 
Nov 12, 13
▲ Outperform · 🎯$45
Price at call : $12.89 — upside +249%
Today : $21.59 — upside +108%
Expected +249% · Actual +18% · Reason (≥ +15%) : ✓ Yes
🎯 on SRPT : 82% (11 calls matureds) · 📊 on Health : 35.8% · +3.2% (53 calls)
+17.8%
stock +18% · XLV +27%
matured Nov 12, 14
▼ Sell · 🎯$10
Price at call : $12.89 — upside -22%
Today : $21.59 — upside -54%
Expected -22% · Actual +18% · Reason (≤ −15%) : ✗ No
🎯 on SRPT : 60% (5 calls matureds) · 📊 on Health : 69.2% · +28.1% (13 calls)
-17.8%
stock +18% · XLV +27%
matured Nov 12, 14
Piper Sandler 
Nov 12, 13
▼ Underweight · 🎯$20
Price at call : $13.16 — upside +52%
Today : $21.59 — upside -7%
Expected +52% · Actual +18% · Reason (≤ −15%) : ✗ No
🎯 on SRPT : 8% (12 calls matureds) · 📊 on Health : 45.8% · +6.9% (249 calls)
-18.0%
stock +18% · XLV +27%
matured Nov 12, 14
Piper Sandler 
Sep 20, 13
▲ Overweight · 🎯$58
Price at call : $47.97 — upside +21%
Today : $21.59 — upside +169%
Expected +21% · Actual -57% · Reason (≥ +15%) : ✗ No
🎯 on SRPT : 8% (12 calls matureds) · 📊 on Health : 45.8% · +6.9% (249 calls)
-56.7%
stock -57% · XLV +26%
matured Sep 20, 14
Baird 
Apr 4, 13
▲ Outperform · 🎯$63
Price at call : $34.43 — upside +83%
Today : $21.59 — upside +192%
Expected +83% · Actual -33% · Reason (≥ +15%) : ✗ No
🎯 on SRPT : 27% (11 calls matureds) · 📊 on Health : 37.8% · -2.8% (82 calls)
-33.1%
stock -33% · XLV +24%
matured Apr 4, 14
Wedbush 
Jan 17, 13
▲ Outperform · 🎯$60
Price at call : $23.97 — upside +150%
Today : $21.59 — upside +178%
Expected +150% · Actual +17% · Reason (≥ +15%) : ✓ Yes
🎯 on SRPT : 82% (11 calls matureds) · 📊 on Health : 35.8% · +3.2% (53 calls)
+16.9%
stock +17% · XLV +36%
matured Jan 17, 14
Wedbush 
Oct 4, 12
▲ Outperform · 🎯$70
Price at call : $37.92 — upside +85%
Today : $21.59 — upside +224%
Expected +85% · Actual +41% · Reason (≥ +15%) : ✓ Yes
🎯 on SRPT : 82% (11 calls matureds) · 📊 on Health : 35.8% · +3.2% (53 calls)
+41.0%
stock +41% · XLV +25%
matured Oct 4, 13
Wedbush 
Jul 24, 12
▲ Outperform · 🎯$26
Price at call : $7.72 — upside +237%
Today : $21.59 — upside +20%
Expected +237% · Actual +378% · Reason (≥ +15%) : ✓ Yes
🎯 on SRPT : 82% (11 calls matureds) · 📊 on Health : 35.8% · +3.2% (53 calls)
+378.0%
stock +378% · XLV +35%
matured Jul 24, 13

Frequently asked questions

Should I buy Sarepta Therapeutics stock?

This isn't buy advice. For Sarepta Therapeutics, the analyst consensus is "Hold", with an average price target of $27.00 (+25% vs the current price). What matters is their past reliability on this stock: the most reliable one is right 90% of the time (10 calls tracked on Sarepta Therapeutics). We show the numbers — you decide.

Is it too late to buy Sarepta Therapeutics? How high can it go?

The most bullish analyst target on Sarepta Therapeutics is $37.00 (+71% above today's price); the average is $27.00. That's the upside they see. Check how reliable those analysts have actually been on Sarepta Therapeutics on our site before trusting it.

Is Sarepta Therapeutics still a good buy?

The most useful "opinion" isn't an opinion — it's a track record: 35 analysts have a real record on Sarepta Therapeutics, the best hitting 90% over 10 calls. Current consensus: "Hold". Make your call on data, not noise.

Will Sarepta Therapeutics stock recover (go back up)?

It's down from its high. We answer with the numbers — the analysts' 12-month target and what happened after its past drops: will SRPT stock recover (go back up)?

Should you invest in Sarepta Therapeutics? The case for and against

The arguments for and against, one by one, from the numbers: why invest in SRPT (and why hesitate).

What has Sarepta Therapeutics's past performance been?

Historical returns and a "how much if I had invested" calculator: SRPT performance & returns.

What is the best month to buy SRPT?

The 12 months ranked by the stock's past returns: best & worst month to buy SRPT.

Are insiders buying SRPT stock?

Executives' and large holders' buys and sells, decoded: insider buying on SRPT.

Other Health stocks

Go further

JPI AI Analyst AI assistant · JPI Invest
Answers based on the tool’s data · not financial advice · full version (free)